ME00862B - Upotreba bisfosfonata za proizvodnju leka za inhibiranje resorpcije kostiju - Google Patents

Upotreba bisfosfonata za proizvodnju leka za inhibiranje resorpcije kostiju

Info

Publication number
ME00862B
ME00862B MEP-2000-18A MEP200018A ME00862B ME 00862 B ME00862 B ME 00862B ME P200018 A MEP200018 A ME P200018A ME 00862 B ME00862 B ME 00862B
Authority
ME
Montenegro
Prior art keywords
alendronate
group
administered
dose
bisphosphonate
Prior art date
Application number
MEP-2000-18A
Other languages
English (en)
Unknown language (me)
Inventor
Anastasia G Daifotis
Arthur C Ll Santora
John A Yates
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43743642&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ME00862(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9717590.5A external-priority patent/GB9717590D0/en
Priority claimed from GBGB9717850.3A external-priority patent/GB9717850D0/en
Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme
Priority claimed from PCT/US1998/014796 external-priority patent/WO1999004773A2/en
Publication of ME00862B publication Critical patent/ME00862B/me

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MEP-2000-18A 1997-07-22 1998-07-17 Upotreba bisfosfonata za proizvodnju leka za inhibiranje resorpcije kostiju ME00862B (me)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US5335197P 1997-07-22 1997-07-22
US5353597P 1997-07-23 1997-07-23
GBGB9717590.5A GB9717590D0 (en) 1997-08-20 1997-08-20 Oral method for treating or preventing abnormal bone resorption
GBGB9717850.3A GB9717850D0 (en) 1997-08-22 1997-08-22 Oral method for treating or preventing abnormal bone resorption
PCT/US1998/014796 WO1999004773A2 (en) 1997-07-22 1998-07-17 Method for inhibiting bone resorption

Publications (1)

Publication Number Publication Date
ME00862B true ME00862B (me) 2008-09-29

Family

ID=43743642

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-2000-18A ME00862B (me) 1997-07-22 1998-07-17 Upotreba bisfosfonata za proizvodnju leka za inhibiranje resorpcije kostiju

Country Status (5)

Country Link
ME (1) ME00862B (sr)
RS (1) RS49979B (sr)
SI (1) SI1175904T1 (sr)
TR (1) TR200805763T2 (sr)
UA (1) UA67748C2 (sr)

Also Published As

Publication number Publication date
UA67748C2 (uk) 2004-07-15
YU1800A (sh) 2002-08-12
SI1175904T1 (sl) 2007-06-30
TR200805763T2 (tr) 2011-05-23
RS49979B (sr) 2008-09-29

Similar Documents

Publication Publication Date Title
US5994329A (en) Method for inhibiting bone resorption
US6015801A (en) Method for inhibiting bone resorption
US6465443B2 (en) Method for inhibiting bone resorption
EP1175904B1 (en) Alendronate for use in the treatment of osteoporosis
GB2336311A (en) Bisphosphonate Dosing Regimen
RS49979B (sr) Upotreba bisfosfonata za proizvodnju leka za inhibiranje resorpcije kostiju
AU2007211965B2 (en) Alendronate for use in the treatment of osteoporosis
AU741818B2 (en) Method for inhibiting bone resorption
AU1567702A (en) Method for inhibiting bone resorption
HRP20000035A2 (en) Method for inhibiting bone resorption
IL153109A (en) An effective pharmaceutical composition for inhibiting bone resorption in humans containing alendronic acid or its acceptable pharmaceutical salt or mixture
MXPA00000789A (en) Method for inhibiting bone resorption
AU2005227418A1 (en) Method for inhibiting bone resorption
AU2451102A (en) Method for inhibiting bone resorption
CA2349744A1 (en) Inhibition bone resorption
HK1024166B (en) Method for inhibiting bone resorption